Cameron N E, Cotter M A
Department of Biomedical Sciences, University of Aberdeen, Scotland, United Kingdom.
J Clin Invest. 1995 Aug;96(2):1159-63. doi: 10.1172/JCI118104.
Oxygen free radical activity is elevated in diabetes mellitus and has been implicated in the etiology of vascular complications. Recent studies have shown that impaired perfusion of nerve endoneurium is a major cause of nerve fiber dysfunction in experimental diabetes. Free radical scavenger treatment prevents the development of nerve conduction abnormalities in diabetic rats. In vitro experiments suggest that autoxidation reactions of glucose, catalyzed by free transition metal ions, are a potential source of free radicals in diabetes. We investigated whether chronic treatment with deferoxamine and trientine, transition metal chelating agents which can prevent autoxidation, could correct nerve conduction and blood flow changes in streptozotocin-diabetic rats. A 20% reduction in sciatic nerve motor conduction velocity after 2 mo diabetes was 90% ameliorated by 2 wk of treatment with deferoxamine or trientine. Sciatic endoneurial nutritive blood flow was 45% reduced by diabetes, but was completely corrected by treatment. In contrast, transition metal chelation had no effect on blood flow or conduction velocity in nondiabetic rats. Thus, the data support the hypothesis that increased free radical activity by glucose autoxidation as a result of impaired transition metal handling is a major cause of early neurovascular deficits in diabetes.
糖尿病患者体内氧自由基活性升高,这与血管并发症的病因有关。最近的研究表明,实验性糖尿病中神经内膜灌注受损是神经纤维功能障碍的主要原因。自由基清除剂治疗可预防糖尿病大鼠神经传导异常的发生。体外实验表明,游离过渡金属离子催化的葡萄糖自氧化反应是糖尿病中自由基的潜在来源。我们研究了用去铁胺和曲恩汀(可预防自氧化的过渡金属螯合剂)进行长期治疗是否能纠正链脲佐菌素诱导的糖尿病大鼠的神经传导和血流变化。糖尿病2个月后坐骨神经运动传导速度降低20%,而去铁胺或曲恩汀治疗2周可改善90%。糖尿病使坐骨神经内膜营养性血流减少45%,但治疗可使其完全恢复正常。相比之下,过渡金属螯合对非糖尿病大鼠的血流或传导速度没有影响。因此,这些数据支持以下假设:由于过渡金属处理受损导致葡萄糖自氧化增加自由基活性是糖尿病早期神经血管缺陷的主要原因。